SlidesetHIV17th International Workshop on Pediatrics & HIV 2025Abstract #14 Effectiveness and Safety of Dolutegravir (DTG) in Infants and Children Aged Under 12-Years at Start of DTG in Europe and Thailand - Intira Jeannie CollinsView Slideset
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #14 Effectiveness and Safety of Dolutegravir (DTG) in Infants and Children Aged Under 12-Years at Start of DTG in Europe and Thailand - Intira Jeannie CollinsView Video
SlidesetHIV17th International Workshop on Pediatrics & HIV 2025Abstract #15 Efficacy of Second-Line Dolutegravir- versus Boosted Protease Inhibitor-Based ART in Children and Adolescents Living with HIV at 96 and 144 Weeks: Pooled Analysis of the ODYSSEY and CHAPAS-4 Trials - Pauline AmugeView Slideset
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #15 Efficacy of Second-Line Dolutegravir- versus Boosted Protease Inhibitor-Based ART in Children and Adolescents Living with HIV at 96 and 144 Weeks: Pooled Analysis of the ODYSSEY and CHAPAS-4 Trials - Pauline AmugeView Video
VMVictor MusiimeMBChB, MMed, PhDSlidesetHIV17th International Workshop on Pediatrics & HIV 2025Debate: All Young Adults with Perinatal HIV Should Receive a Statin to Reduce the Risk of Cardiovascular-Related Morbidity and Mortality - Con Standpoint - Victor MusiimeView Slideset
SlidesetHIVTuberculosis17th International Workshop on Pediatrics & HIV 2025Abstract #17 Effect of TB Preventive Treatment on TB Incidence and Non-TB-Related Mortality among Children and Adolescents Living with HIV Initiated on Antiretroviral Therapy in Cameroon, 2020-2022 - Boris Kevin TchoungaView Slideset
VideoHIVTuberculosis17th International Workshop on Pediatrics & HIV 2025Abstract #17 Effect of TB Preventive Treatment on TB Incidence and Non-TB-Related Mortality among Children and Adolescents Living with HIV Initiated on Antiretroviral Therapy in Cameroon, 2020-2022 - Boris Kevin TchoungaView Video
SlidesetHIV17th International Workshop on Pediatrics & HIV 2025Abstract #18 Infectious Morbidity among Children HIV-Exposed, Uninfected in South Africa: Elevated Risk in Infancy But Not Thereafter - Kim AndersonView Slideset
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #18 Infectious Morbidity among Children HIV-Exposed, Uninfected in South Africa: Elevated Risk in Infancy But Not Thereafter - Kim AndersonView Video
SlidesetHIV17th International Workshop on Pediatrics & HIV 2025Abstract #19 Growth Trajectories Before and After Switching to Dolutegravir in Children Living with HIV in the ODYSSEY Trial - Man K. ChanView Slideset
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #19 Growth Trajectories Before and After Switching to Dolutegravir in Children Living with HIV in the ODYSSEY Trial - Man K. ChanView Video
NMNelly MugoMbCHB, MMed (ObGyn), MPHSlidesetHIV17th International Workshop on Pediatrics & HIV 2025 HPV Vaccine and Cervical Cancer Prevention in Africa - Nelly MugoView Slideset
